Skip to main content
Caplight Logo









MabGenesis株式会社

MabGenesis株式会社

Private
YokohamaHealthcare & Life Scienceshttps://mabgenesis.com/

Last Round

VC Round

Dec 24, 2024

Est. Valuation

$21.66M

Total Funding Raised

$2.57M

Company Overview

MabGenesis株式会社 is a Japanese biotechnology company that develops therapeutic monoclonal antibody drugs for humans and companion animals.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibody therapyantibody discoveryveterinary antibodiescompanion animal healthdrug discovery platformanimal pharmaphage displaydrug licensingantibody librarydrug discovery partnershipmAbsmembrane protein targetscanine therapeuticsfeline therapeuticszoonotic diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MabGenesis株式会社 Comparables

Compare MabGenesis株式会社 with similar companies based on industry and business-model similarity.

MabGenesis株式会社 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vetigenics Inc.
80%
iBody Inc.
78%
MOLCURE Inc.
76%

MabGenesis株式会社 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 24, 2024
VC RoundDec 2, 2022
Series A ExtensionJun 1, 2020
SeedJan 19, 2020

MabGenesis株式会社 Investors

Notable investors and investment history

MabGenesis株式会社 investors
InvestorRounds
Beyond Next VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2024

    $3M raised from venture capital and government investors.

  • Nov 13, 2024

    Monthly visitors increased 60% MoM.

MabGenesis株式会社 Filings

Explore SEC and related filing metadata, where available.

MabGenesis株式会社 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MabGenesis株式会社's valuation, stock price, and market status.

Is MabGenesis株式会社 a public or private company?

MabGenesis株式会社 is a private company.

What is the current stock price of MabGenesis株式会社?

MabGenesis株式会社 is a private company with no public stock price. No recent secondary market data is available.

How much is MabGenesis株式会社 worth (valuation)?

Valuation information for MabGenesis株式会社 is not publicly available.

Can I buy MabGenesis株式会社 stock?

MabGenesis株式会社 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MabGenesis株式会社's last funding round?

Funding round information for MabGenesis株式会社 is not publicly available.

Who are the main investors in MabGenesis株式会社?

Investor information for MabGenesis株式会社 is not publicly disclosed.

Will MabGenesis株式会社 IPO soon?

No public IPO plans have been announced for MabGenesis株式会社.

How can I track MabGenesis株式会社 secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MabGenesis株式会社's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersYokohama
Employee Range3
Year Founded2019
Last FundingDec 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?